Trial intelligence / Profile preview

Does statin therapy reduce sympathoexcitation in hypertension

2007-000310-36Phase 4Completed

Sponsor
Radboud University Medical Center
Start
Jun 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of atorvastatin in hypertension (HTN), sponsored by Radboud University Medical Center. Primary endpoints: Effect of atorvastatin on sympathetic activity and Effect of atorvastatin on blood pressure. Started Jun 2007; status: completed.

02

Drugs

atorvastatin
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on 2007-000310-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-000310-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call